|
Clinical Trials and Observations
Citations 161-170 of 2742 total displayed.
|
Past content
(since May 1998):
|
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
- Kenneth R. Carson, Andrew M. Evens, Elizabeth A. Richey, Thomas M. Habermann, Daniele Focosi, John F. Seymour, Jacob Laubach, Susie D. Bawn, Leo I. Gordon, Jane N. Winter, Richard R. Furman, Julie M. Vose, Andrew D. Zelenetz, Ronac Mamtani, Dennis W. Raisch, Gary W. Dorshimer, Steven T. Rosen, Kenji Muro, Numa R. Gottardi-Littell, Robert L. Talley, Oliver Sartor, David Green, Eugene O. Major, and Charles L. Bennett
Blood 2009; 113: 4834-4840.
[Abstract]
[Full text]
[PDF]
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide
- Judith E. Karp, Karen Flatten, Eric J. Feldman, Jacqueline M. Greer, David A. Loegering, Rebecca M. Ricklis, Lawrence E. Morris, Ellen Ritchie, B. Douglas Smith, Valerie Ironside, Timothy Talbott, Gail Roboz, Son B. Le, Xue Wei Meng, Paula A. Schneider, Nga T. Dai, Alex A. Adjei, Steven D. Gore, Mark J. Levis, John J. Wright, Elizabeth Garrett-Mayer, and Scott H. Kaufmann
Blood 2009; 113: 4841-4852.
[Abstract]
[Full text]
[PDF]
R2* magnetic resonance imaging of the liver in patients with iron overload
- Jane S. Hankins, M. Beth McCarville, Ralf B. Loeffler, Matthew P. Smeltzer, Mihaela Onciu, Fredric A. Hoffer, Chin-Shang Li, Winfred C. Wang, Russell E. Ware, and Claudia M. Hillenbrand
Blood 2009; 113: 4853-4855.
[Abstract]
[Full text]
[PDF]
Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance
- Junji Hiraga, Akihiro Tomita, Takumi Sugimoto, Kazuyuki Shimada, Masafumi Ito, Shigeo Nakamura, Hitoshi Kiyoi, Tomohiro Kinoshita, and Tomoki Naoe
Blood 2009; 113: 4885-4893.
[Abstract]
[Full text]
[PDF]
Studies of the immune response in heparin-induced thrombocytopenia
- Theodore E. Warkentin, Jo-Ann I. Sheppard, Jane C. Moore, Richard J. Cook, and John G. Kelton
Blood 2009; 113: 4963-4969.
[Abstract]
[Full text]
[PDF]
The temporal profile of the anti-PF4/heparin immune response
- Andreas Greinacher, Thomas Kohlmann, Ulrike Strobel, Jo-Ann I. Sheppard, and Theodore E. Warkentin
Blood 2009; 113: 4970-4976.
[Abstract]
[Full text]
[PDF]
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
- Ola Landgren, Ethel S. Gilbert, J. Douglas Rizzo, Gérard Socié, Peter M. Banks, Kathleen A. Sobocinski, Mary M. Horowitz, Elaine S. Jaffe, Douglas W. Kingma, Lois B. Travis, Mary E. Flowers, Paul J. Martin, H. Joachim Deeg, and Rochelle E. Curtis
Blood 2009; 113: 4992-5001.
[Abstract]
[Full text]
[PDF]
Infarction of tumor vessels by NGR-peptide–directed targeting of tissue factor: experimental results and first-in-man experience
- Ralf Bieker, Torsten Kessler, Christian Schwöppe, Teresa Padró, Thorsten Persigehl, Christoph Bremer, Johannes Dreischalück, Astrid Kolkmeyer, Walter Heindel, Rolf M. Mesters, and Wolfgang E. Berdel
Blood 2009; 113: 5019-5027.
[Abstract]
[Full text]
[PDF]
Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993
- Adele K. Fielding, Jacob M. Rowe, Susan M. Richards, Georgina Buck, Anthony V. Moorman, I. Jill Durrant, David I. Marks, Andrew K. McMillan, Mark R. Litzow, Hillard M. Lazarus, Letizia Foroni, Gordon Dewald, Ian M. Franklin, Selina M. Luger, Elisabeth Paietta, Peter H. Wiernik, Martin S. Tallman, and Anthony H. Goldstone
Blood 2009; 113: 4489-4496.
[Abstract]
[Full text]
[PDF]
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study
- Michele Baccarani, Gianantonio Rosti, Fausto Castagnetti, Ibrahim Haznedaroglu, Kimmo Porkka, Elisabetta Abruzzese, Giuliana Alimena, Hans Ehrencrona, Henrik Hjorth-Hansen, Veli Kairisto, Luciano Levato, Giovanni Martinelli, Arnon Nagler, Johan Lanng Nielsen, Ugur Ozbek, Francesca Palandri, Fausto Palmieri, Fabrizio Pane, Giovanna Rege-Cambrin, Domenico Russo, Giorgina Specchia, Nicoletta Testoni, Ole Weiss-Bjerrum, Giuseppe Saglio, and Bengt Simonsson
Blood 2009; 113: 4497-4504.
[Abstract]
[Full text]
[PDF]
|
|
